| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |